Do higher complement C4 levels reflect increased complement activity during inflammatory or immune-activated states?

The complement system serves as a bridge between innate and adaptive immunity, and serum levels of specific proteins like C4 often fluctuate in response to systemic inflammation. While C4 is frequently measured to detect deficiencies or consumption, its role as a positive acute-phase reactant means that elevated levels can indeed signal an active immune response.

Clinical and mechanistic evidence

The relationship between C4 and inflammation is driven by hepatic synthesis in response to cytokine signaling.

• Acute-Phase Response: Complement C4 is synthesized primarily by hepatocytes. During inflammatory or immune-activated states, pro-inflammatory cytokines—specifically Interleukin-1 (IL-1), Interleukin-6 (IL-6), and Tumor Necrosis Factor-alpha (TNF-α)—upregulate the pretranslational expression of the C4 gene.
• Correlation with Inflammatory Markers: Research indicates that in various inflammatory conditions, such as certain infections and osteoarthritis, serum C4 concentrations correlate positively with standard markers like C-Reactive Protein (CRP) and Erythrocyte Sedimentation Rate (ESR). In these contexts, the increased production of C4 outweighs its utilization in the complement cascade.
• Production vs. Consumption Dynamics: The net level of serum C4 represents a dynamic equilibrium. While inflammation triggers increased production, the actual "activity" of the complement system (the proteolytic cleavage of C4 into fragments like C4a and C4b) consumes the protein. Therefore, high levels suggest that hepatic synthesis is successfully compensating for, or exceeding, the rate of consumption.
• Disease Specificity: Elevated C4 is often observed in chronic inflammatory states where the classical pathway is not being hyper-activated to the point of exhaustion. This contrasts with conditions like active Systemic Lupus Erythematosus (SLE), where massive consumption typically leads to low serum C4 despite the presence of inflammation.

Bottom line

Higher complement C4 levels are a biologically plausible indicator of increased complement activity and systemic inflammation, as C4 acts as a positive acute-phase reactant. However, because levels represent the balance between hepatic synthesis and proteolytic consumption, they should be interpreted alongside other inflammatory markers and the specific clinical presentation.